Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay.

Journal of virological methods - 1 Mar 2002

Ross R S, Viazov S, Sarr S, Hoffmann S, Kramer A, Roggendorf M

Abstract excerpt

Quantitation of hepatitis C virus (HCV) RNA has become an important tool in different clinical settings and is used extensively for pretreatment evaluation of patients infected chronically with HCV. In this study, the performance characteristics of the third generation branched DNA-based signal amplification assay (bDNA 3.0) for HCV RNA quantitation were established. The new assay version showed an analytical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Hepacivirus
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Polymerase Chain Reaction

Share to Reference Standards

Share to Reproducibility of Results

Share to RNA, Viral

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 11849694
DOI: 10.1016/s0166-0934(01)00433-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay.PMID 11849694Read ↗

Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays.Semantic proximity Read ↗

Multicenter Evaluation of the VERSANT Hepatitis B Virus DNA 3.0 AssaySemantic proximity Read ↗

Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.Semantic proximity Read ↗

Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology.Semantic proximity Read ↗

Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.Semantic proximity Read ↗

Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5.Semantic proximity Read ↗

Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNASemantic proximity Read ↗

Comparison of real-time quantitative polymerase chain reaction with three other assays for quantitation of hepatitis C virus.Semantic proximity Read ↗

Diagnostic tests for hepatitis C.Semantic proximity Read ↗

Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 Assays for quantification of hepatitis C virus RNA in serum.Semantic proximity Read ↗

Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay.Semantic proximity Read ↗

Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infections.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.